VGM & Associates Launches Partnership with O2 Concepts
on August 01, 2023
(Waterloo, Iowa) – VGM & Associates has signed a new agreement with O2 Concepts. O2 Concepts provides innovative portable oxygen concentrators with facilities based in Middlebury, CT.
The novel design of their devices provides both continuous flow and high-volume pulse dose oxygen in a 24/7 environment, and are uniquely capable of delivering the most clinical oxygen therapy available for better mobility and quality of life. O2 Concepts also offers DNA Technology®, their proprietary, device-initiated connectivity solution that connects provider organizations with their device fleets via the O2 Concepts DNA Portal.
"Embracing progress, we proudly expand the VGM Respiratory portfolio with the addition of O2 Concepts,” said Boone Lockard, director of VGM Respiratory. “With O2 Concepts’ innovative POC portfolio and revolutionary DNA platform, we enhance our ability to meet the evolving needs of VGM members and patients. This partnership is a step forward in our commitment to delivering exceptional respiratory care solutions."
“We are extremely pleased to join the VGM Vendor Partners program and collaborate with VGM Respiratory and Member Services teams in providing our products to their member community,” said Elby Beal, CEO of O2 Concepts. “We are excited to bring the market-leading performance and reliability of our devices and technology to the VGM membership and share our expertise in the use of POCs and utilizing technology to enhance and evolve their fleet management systems.”
About VGM & Associates
VGM & Associates is the nation’s largest and most comprehensive member service organization (MSO) for post-acute healthcare including DME/HME, respiratory, sleep, wound care, complex rehab, women’s health, home modifications, and orthotics and prosthetics providers. 3,000 providers with nearly 7,000 locations rely on VGM to connect them to valuable resources every single day. For more information, visit www.vgm.com.
About O2 Concepts
O2 Concepts is a US manufacturer of innovative portable oxygen concentrators specializing in devices designed and engineered for the demands of the DME industry. With the capacity to function as both stationary and portable devices, their POCs are uniquely capable of delivering the most clinical oxygen therapy that technology has to offer for improved patient outcomes, lifestyle and mobility.
At the heart of every O2 Concepts POC is their proprietary DNA Technology — a device-initiated connectivity solution that provides DMEs and clinicians with daily critical data for new levels of operating efficiency, asset management, inventory control, and improved patient outcomes. To learn more, visit o2-concepts.com.